Dollar cost averaging (DCA) in ARQT means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More ARQT Analysis
ARQT DCA Calculator
Dollar Cost Averaging — Arcutis Biotherapeutics, Inc.
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return+97.5%
Final Value$94.8K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return+71.8%
Final Value$81.6K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return+48.3%
Final Value$71.2K
Worst possible — still beats not investing
Best vs Worst gap49.3 pp
Your timing vs best-25.8%
Your timing vs worst+23.5%
If You Keep Investing…
Based on this stock's historical CAGR of 9.0%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$20K~1.1x your moneyfrom $18K invested
5 Years$37K~1.2x your moneyfrom $30K invested
10 Years$95K~1.6x your moneyfrom $60K invested
20 Years$320K~2.7x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.1x your money
5 Years~1.2x your money
10 Years~1.6x your money
20 Years~2.7x your money
$100/mo
$4K+$495 est. gain
$7K+$1K est. gain
$19K+$7K est. gain
$64K+$40K est. gain
$250/mo
$10K+$1K est. gain
$19K+$4K est. gain
$47K+$17K est. gain
$160K+$100K est. gain
$500/mo
$20K+$2K est. gain
$37K+$7K est. gain
$95K+$35K est. gain
$320K+$200K est. gain
$1,000/mo
$41K+$5K est. gain
$75K+$15K est. gain
$190K+$70K est. gain
$641K+$401K est. gain
* Projection assumes historical CAGR of 9.0% continues. Actual returns will vary.
Your DCA Results by Date
76 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Jan 31, 2020
$21.80
$10,000
$10,000
+0.00%
$0
Mar 2, 2020
$27.40
$10,500
$13,069
+24.46%
$2,569
Apr 2, 2020
$25.84
$11,000
$12,825
+16.59%
$1,825
May 4, 2020
$25.67
$11,500
$13,240
+15.13%
$1,740
Jun 2, 2020
$31.34
$12,000
$16,665
+38.87%
$4,665
Jul 2, 2020
$32.01
$12,500
$17,521
+40.17%
$5,021
Aug 3, 2020
$25.89
$13,000
$14,671
+12.86%
$1,671
Sep 2, 2020
$25.39
$13,500
$14,888
+10.28%
$1,388
Oct 2, 2020
$23.30
$14,000
$14,162
+1.16%
$162
Nov 2, 2020
$18.72
$14,500
$11,879
-18.08%
$-2,621
Dec 2, 2020
$25.75
$15,000
$16,839
+12.26%
$1,839
Jan 4, 2021
$28.44
$15,500
$19,099
+23.22%
$3,599
Feb 2, 2021
$36.10
$16,000
$24,743
+54.64%
$8,743
Mar 2, 2021
$35.04
$16,500
$24,516
+48.58%
$8,016
Apr 5, 2021
$27.76
$17,000
$19,923
+17.19%
$2,923
May 3, 2021
$34.75
$17,500
$25,439
+45.37%
$7,939
Jun 2, 2021
$26.74
$18,000
$20,075
+11.53%
$2,075
Jul 2, 2021
$26.35
$18,500
$20,282
+9.63%
$1,782
Aug 2, 2021
$23.28
$19,000
$18,419
-3.06%
$-581
Sep 2, 2021
$22.16
$19,500
$18,033
-7.52%
$-1,467
Oct 4, 2021
$24.96
$20,000
$20,812
+4.06%
$812
Nov 2, 2021
$22.95
$20,500
$19,636
-4.22%
$-864
Dec 2, 2021
$16.00
$21,000
$14,189
-32.43%
$-6,811
Jan 3, 2022
$22.79
$21,500
$20,711
-3.67%
$-789
Feb 2, 2022
$14.86
$22,000
$14,004
-36.34%
$-7,996
Page 1 of 4
Frequently Asked Questions
Common questions about DCA investing in ARQT
Investing $500 per month in Arcutis Biotherapeutics, Inc. (ARQT) over the past 6 years would be worth approximately $82K today. That's +71.8% total return on $48K invested, with a +9.0% compound annual growth rate (CAGR).